BioGend Therapeutics , Ltd. Other Liabilities

BioGend Therapeutics , Ltd. (6733.TWO) currently reports a other liabilities of $0 as of September 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore BioGend Therapeutics , Ltd.'s other liabilities history and peer comparisons.

BioGend Therapeutics , Ltd.'s other liabilities changed from $0 to $0 (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

BioGend Therapeutics , Ltd. reported $0 in other liabilities as of September 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other liabilities of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for BioGend Therapeutics , Ltd., and consider following 6733.TWO for alerts when major investors trade the stock.

BioGend Therapeutics , Ltd. is classified in the Healthcare sector. On other liabilities, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 6733.TWO with unrelated industries.